These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35737351)
41. Antibacterial activity of grapefruit peel extracts and green-synthesized silver nanoparticles. Arsène MMJ; Podoprigora IV; Davares AKL; Razan M; Das MS; Senyagin AN Vet World; 2021 May; 14(5):1330-1341. PubMed ID: 34220139 [TBL] [Abstract][Full Text] [Related]
42. Effectiveness of topical green tea against multidrug-resistant Umashankar N; Pemmanda B; Gopkumar P; Hemalatha AJ; Sundar PK; Prashanth HV Indian J Dermatol Venereol Leprol; 2018; 84(2):163-168. PubMed ID: 29146890 [TBL] [Abstract][Full Text] [Related]
43. In Vitro Efficiency of Antimicrobial Peptides against Staphylococcal Pathogens Associated with Canine Pyoderma. Jarosiewicz M; Garbacz K; Neubauer D; Kamysz W Animals (Basel); 2020 Mar; 10(3):. PubMed ID: 32168952 [TBL] [Abstract][Full Text] [Related]
44. Bactericidal activity of ethanolic extracts of propolis against Staphylococcus aureus isolated from mastitic cows. Santana HF; Barbosa AA; Ferreira SO; Mantovani HC World J Microbiol Biotechnol; 2012 Feb; 28(2):485-91. PubMed ID: 22806843 [TBL] [Abstract][Full Text] [Related]
45. A Comparison between Antibacterial Activity of Propolis and Aloe vera on Enterococcus faecalis (an In Vitro Study). Ehsani M; Amin Marashi M; Zabihi E; Issazadeh M; Khafri S Int J Mol Cell Med; 2013; 2(3):110-6. PubMed ID: 24551800 [TBL] [Abstract][Full Text] [Related]
46. Potential Effects of Romanian Propolis Extracts against Pathogen Strains. Vică ML; Glevitzky M; Heghedűş-Mîndru RC; Glevitzky I; Matei HV; Balici S; Popa M; Teodoru CA Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270324 [TBL] [Abstract][Full Text] [Related]
48. Canine superficial bacterial pyoderma: evaluation of skin surface sampling methods and antimicrobial susceptibility of causal Staphylococcus isolates. Ravens PA; Vogelnest LJ; Ewen E; Bosward KI; Norris JM Aust Vet J; 2014 May; 92(5):149-55. PubMed ID: 24766044 [TBL] [Abstract][Full Text] [Related]
49. Antibacterial properties studies of trunk barks of Terminalia ivorensis, a commercial and medicinal species on some methicillin-resistant Staphylococci species strains. Coulibaly K; Zirihi GN; Guessennd-Kouadio N; Oussou KR; Dosso M Afr Health Sci; 2014 Sep; 14(3):753-6. PubMed ID: 25352898 [TBL] [Abstract][Full Text] [Related]
50. Minimum Inhibitory Concentrations of Vancomycin and Daptomycin Against Methicillin-resistant Staphylococcus Aureus Isolated from Various Clinical Specimens: A Study from South India. Moses VK; Kandi V; Rao SKD Cureus; 2020 Jan; 12(1):e6749. PubMed ID: 32140317 [TBL] [Abstract][Full Text] [Related]
51. Synergistic Effects of Propolis Combined with 2-Phenoxyethanol and Antipyretics on the Growth of Grecka K; Szweda P Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33557393 [TBL] [Abstract][Full Text] [Related]
52. Levonadifloxacin (WCK 771) exerts potent intracellular activity against Dubois J; Dubois M J Med Microbiol; 2019 Dec; 68(12):1716-1722. PubMed ID: 31689174 [No Abstract] [Full Text] [Related]
53. Natural Occurring Phenolic Derivatives from Mauritia flexuosa (Buriti) Stems and Their Potential Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus (MRSA). de Oliveira DM; de Oliveira DBC; Nunes YRF; de Almeida Alves TM; Kohlhoff M; Andrade AA; Cota BB Chem Biodivers; 2022 Mar; 19(3):e202100788. PubMed ID: 35146890 [TBL] [Abstract][Full Text] [Related]
54. Efficacy of olanexidine gluconate in canine superficial pyoderma: a randomised, single-blinded controlled trial. Hsiao YH; Imanishi I; Iyori K Vet Dermatol; 2021 Dec; 32(6):664-e174. PubMed ID: 34796563 [TBL] [Abstract][Full Text] [Related]
55. Synergistic antimicrobial activity of melittin with clindamycin on the expression of encoding exfoliative toxin in Staphylococcus aureus. Mahmoudi H; Alikhani MY; Imani Fooladi AA Toxicon; 2020 Aug; 183():11-19. PubMed ID: 32450143 [TBL] [Abstract][Full Text] [Related]
56. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections. Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316 [TBL] [Abstract][Full Text] [Related]
58. Hamza M; Nadir M; Mehmood N; Farooq A Indian J Pharmacol; 2016; 48(6):710-714. PubMed ID: 28066112 [TBL] [Abstract][Full Text] [Related]
59. Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011. Sader HS; Flamm RK; Jones RN Antimicrob Agents Chemother; 2013 Jul; 57(7):3178-81. PubMed ID: 23629712 [TBL] [Abstract][Full Text] [Related]
60. Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus. Chan EWL; Yee ZY; Raja I; Yap JKY J Glob Antimicrob Resist; 2017 Sep; 10():70-74. PubMed ID: 28673701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]